Literature DB >> 9325472

Peripheral neuropathy in individuals with HIV infection in Zimbabwe.

O Parry1, J Mielke, A S Latif, S Ray, L F Levy, S Siziya.   

Abstract

Peripheral neuropathy is associated with HIV infection. The prevalence and types of peripheral neuropathy encountered in a randomly-selected HIV infected African population at different stages of disease were investigated. HIV positive individuals were categorized into 1 of 3 groups: asymptomatic, symptomatic and AIDS. HIV negative individuals formed the control group. Nerve conduction data were obtained using standard electrophysiological procedures and CD4+ levels were measured. The type of neuropathy was determined from the history, clinical presentation and electrophysiological abnormalities. The prevalence of peripheral neuropathy was 44%: subclinical neuropathy (SCN) accounted for 56%, acute inflammatory demyelinating polyneuropathy (AIDP) for 15% and distal symmetrical polyneuropathy (DSPN) for 22% of cases of neuropathy. SCN was found in all categories whereas AIDP predominated in the symptomatic category and DSPN in individuals with AIDS. The pattern and frequency of neuropathies seen in our African population is similar to that reported from other continents.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Biology; Case Control Studies; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Examinations And Diagnoses; Hiv Infections; Laboratory Examinations And Diagnoses; Neurologic Effects; Physiology; Research Methodology; Research Report; Signs And Symptoms; Studies; Viral Diseases; Zimbabwe

Mesh:

Year:  1997        PMID: 9325472     DOI: 10.1111/j.1600-0404.1997.tb00272.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  12 in total

1.  Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study.

Authors:  K Robertson; H Jiang; J Kumwenda; K Supparatpinyo; S Evans; T B Campbell; R Price; S Tripathy; N Kumarasamy; A La Rosa; B Santos; M T Silva; S Montano; C Kanyama; S Faesen; R Murphy; C Hall; C M Marra; C Marcus; B Berzins; R Allen; M Housseinipour; F Amod; I Sanne; J Hakim; A Walawander; A Nair
Journal:  Clin Infect Dis       Date:  2012-06-01       Impact factor: 9.079

2.  Prevalence, self-care behaviors, and self-care activities for peripheral neuropathy symptoms of HIV/AIDS.

Authors:  Patrice K Nicholas; Joachim Voss; Dean Wantland; Teri Lindgren; Emily Huang; William L Holzemer; Yvette Cuca; Shahnaz Moezzi; Carmen Portillo; Suzanne Willard; John Arudo; Kenn Kirksey; Inge B Corless; María E Rosa; Linda Robinson; Mary J Hamilton; Elizabeth Sefcik; Sarie Human; Marta Rivero-Mendez; Mary Maryland; Kathleen M Nokes; Lucille Eller; Jeanne Kemppainen; Carol Dawson-Rose; John M Brion; Elli H Bunch; Maureen Shannon; Thomas P Nicholas; Ana Viamonte-Ros; Catherine A Bain
Journal:  Nurs Health Sci       Date:  2010-03       Impact factor: 1.857

3.  Pain related potentials by electrical stimulation of skin for detection of small-fiber neuropathy in HIV.

Authors:  Zaza Katsarava; Ozgüt Yaldizli; Christina Voulkoudis; Hans-Christoph Diener; Helger Kaube; Matthias Maschke
Journal:  J Neurol       Date:  2006-10-24       Impact factor: 4.849

4.  Global HIV neurology: a comprehensive review.

Authors:  Kiran T Thakur; Alexandra Boubour; Deanna Saylor; Mitashee Das; David R Bearden; Gretchen L Birbeck
Journal:  AIDS       Date:  2019-02-01       Impact factor: 4.177

5.  Evaluation of a screening tool for the identification of neurological disorders in rural Uganda.

Authors:  Andy Tran; Kiran T Thakur; Noeline Nakasujja; Gertrude Nakigozi; Alice Kisakye; James Batte; Richard Mayanja; Aggrey Anok; Ronald H Gray; Maria J Wawer; Leah H Rubin; Ned Sacktor; Deanna Saylor
Journal:  J Neurol Sci       Date:  2020-12-24       Impact factor: 3.181

6.  A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings.

Authors:  Kevin Robertson; Johnstone Kumwenda; Khuanchai Supparatpinyo; Jeanne H Jiang; Scott Evans; Thomas B Campbell; Richard W Price; Robert Murphy; Colin Hall; Christina M Marra; Cheryl Marcus; Baiba Berzins; Reena Masih; Breno Santos; Marcus T Silva; N Kumarasamy; Ann Walawander; Apsara Nair; Srikanth Tripathy; Cecilia Kanyama; Mina Hosseinipour; Silvia Montano; Alberto La Rosa; Farida Amod; Ian Sanne; Cindy Firnhaber; James Hakim; Pim Brouwers
Journal:  J Neurovirol       Date:  2011-07-23       Impact factor: 2.643

Review 7.  Behavioral and neurophysiological hallmarks of simian immunodeficiency virus infection in macaque monkeys.

Authors:  P D Cheney; M Riazi; J M Marcario
Journal:  J Neurovirol       Date:  2008-08       Impact factor: 2.643

8.  Impact of long-term treatment with neurotoxic dideoxynucleoside antiretrovirals: implications for clinical care in resource-limited settings.

Authors:  C F Hung; S A Gibson; S L Letendre; J T Lonergan; J A Marquie-Beck; F Vaida; R J Ellis
Journal:  HIV Med       Date:  2008-07-21       Impact factor: 3.180

9.  Influence of Age and Neurotoxic HAART Use on Frequency of HIV Sensory Neuropathy.

Authors:  Olajumoke Oshinaike; Akinsegun Akinbami; Oluwadamilola Ojo; Anthonia Ogbera; Njideka Okubadejo; Frank Ojini; Mustapha Danesi
Journal:  AIDS Res Treat       Date:  2012-04-17

Review 10.  HIV-related neuropathy: current perspectives.

Authors:  Sonja G Schütz; Jessica Robinson-Papp
Journal:  HIV AIDS (Auckl)       Date:  2013-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.